Logo

NEWSBRIEF: Illumina Gets $1 Million from SBIR

May 10, 2002

NEW YORK, May 10-Illumina said today that it had been granted $1 million through the National Institutes of Health's Small Business Innovation Research program to develop its bead array technology.

 

The award, a phase 2 grant, will underwrite Illumina's efforts to create a highly parallel system for microarray experiments.

 

Illumina, based in San Diego, Calif., is publicly owned.

 

For more information, see the company website.

Breaking News
The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.